Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

The use of Journavx for moderate to severe pain has not been studied beyond 14 ... The drug is contraindicated in patients taking strong CYP3A inhibitors and should be avoided in those with ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

“There is relatively strong safety data for short-term use ... weeks — but it is common for doctors to prescribe acute pain medications off-label for chronic pain. That, he said, is worrying. “ ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.